GLANCOS POLAND FABRYKA CHEMICZNO-KOSMETYCZNA SPÓŁKA Z OGRANICZONĄ O...

TAX ID8560000531

KRS0000248062

Share capital238,000.00 zł

Not confirmed

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. BOCZNA 7, 72-100 ŁOZIENICA

Show on map

Activity type

manufacturer

Register Data

Full name

GLANCOS POLAND FABRYKA CHEMICZNO-KOSMETYCZNA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. BOCZNA 7, 72-100 ŁOZIENICA

Show on map

NIP

8560000531

REGON

810522177

KRS

0000248062

Legal form

limited liability company

ALEO.com Registration Date

2023-03-29

Register Address

UL. BOCZNA 7, 72-100 ŁOZIENICA

Date of registration in KRS

2006-01-04

Date of commencement of economic activity

2006-01-04

Act signature

SZ.XIII NS-REJ.KRS/11136/24/562

Pkd codes

20.42.Z - Manufacture of perfumes and toilet preparations

20.41.Z - Manufacture of soap and detergents, cleaning and polishing preparations

46.45.Z - Wholesale of perfume and cosmetics

47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores

Payer VAT status

Active

Vat list bank account(s)

PL86 1050 1559 1000 0090 3291 1274

PL70 1050 1559 1000 0090 8206 2820

PL11 1050 1559 1000 0090 3291 1266

PL03 1140 1137 0000 3102 8500 1020

PL04 1140 1137 0000 3102 8500 1002

PL31 1140 1137 0000 3102 8500 1001

PL52 1140 1137 0000 3102 8500 1011

Show more bank accounts from VAT list (4)

Company authorities

representation authorityMANAGEMENT

representation type

W RAZIE POWOŁANIA ZARZĄDU WIELOOSOBOWEGO, SPÓŁKĘ REPREZENTUJE KAŻDY Z CZŁONKÓW ZARZĄDU SAMODZIELNIE.

MANAGEMENT

Mohammad Sharif Sarwari

Company Director, 73 years old

Farhad Sarwari

Company Director

shareholders

PHH PHARMA & HEALTH HOLDING AG

100% 238 udziałów o łącznej wartości 238.000,00 złotych

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022	2023
	M PLN	M PLN	M PLN	%
Gross profit (loss)	1,7	0,7	2,2	215,9
EBITDA	2	1,1	2,7	159,4
Short time liabilities	2,8	3,1	6,9	119,1
Equity capital	10,7	11,2	13	16
Operating profit (EBIT)	1,7	0,7	2,4	226
Assets	14,1	14,9	30,4	104,4
Net profit (loss)	1,4	0,5	1,8	237,8
Cash	0,4	0,1	1,2	908,3
Net income from sale	13,7	13,3	17,5	31,2
Liabilities and provisions for liabilities	3,5	3,7	17,5	371,2
Working assets	8	8,4	11	31
Depreciation	0,3	0,3	0,3	1,6
	%	%	%	p.p.
Profitability of capital	13,5	4,7	13,8	9,1
Equity capital to total assets	75,5	75,1	42,6	-32,5
Gross profit margin	12,1	5,3	12,8	7,5
EBITDA Margin	14,3	7,9	15,6	7,7
	Days	Days	Days	Days
Short term commitment turnover cycle	73	86	143	57

Current financial liquidity indicator	2.405614137649536	2.2624123096466064	1.4812284708023071	-0,8
Net dept to EBITDA	-0.062164511531591415	0.004672659561038017	4.005062103271484	4